Cigarette for Chronic Obstructive Pulmonary Disease
This trial studies if switching from cigarettes to a Tobacco Heating System can slow COPD symptom progression and improve symptoms in smokers with mild-moderate COPD.
- Chronic Obstructive Pulmonary Disease
- Tobacco Use
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Exclusion CriteriaYou will be eligible for the trial if you check “No” for criteria below:
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Other reimbursement is provided
Other forms of reimbursement are provided for this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does this trial allow for participants under 45 years of age?
"This trial is limited to patients aged 40-65 years old. However, individuals outside of this age range can access 38 studies for those under 18 and 425 trials for seniors beyond the age of 65."
Are there a plethora of Canadian medical facilities conducting this research endeavor?
"Presently, 65 medical sites across Clearwater, Lakeland and Largo are recruiting for this research project. It would be beneficial to choose the clinic nearest you in order to reduce your travel burden if you become a trial participant."
What is the aggregate number of participants in this trial?
"Confirmed. According to the information displayed on clinicaltrials.gov, this study is actively looking for participants and was initially posted December 16th 2022. The trial will include 1895 individuals being recruited from 65 different medical sites."
Is enrollment open presently for this experiment?
"Affirmative. Clinicaltrials.gov corroborates that the research is actively searching for 1895 participants to be recruited from 65 different medical facilities. This initiative was initially posted on December 16th 2022 and most recently updated Jun 20th 2023."
What criteria must be fulfilled in order to qualify for participation in this experiment?
"In order to be included in the trial, individuals must have chronic obstructive pulmonary disease and should lie within a 40-65 age range. Altogether, 1895 patients are desired for this research."